annual CFF:
-$565.00K-$281.90M(-100.20%)Summary
- As of today (June 2, 2025), EVH annual cash flow from financing activities is -$565.00 thousand, with the most recent change of -$281.90 million (-100.20%) on December 31, 2024.
- During the last 3 years, EVH annual CFF has risen by +$28.98 million (+98.09%).
- EVH annual CFF is now -100.20% below its all-time high of $281.34 million, reached on December 31, 2023.
Performance
EVH Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$107.85M+$10.91M(+11.26%)Summary
- As of today (June 2, 2025), EVH quarterly cash flow from financing activities is $107.85 million, with the most recent change of +$10.91 million (+11.26%) on March 31, 2025.
- Over the past year, EVH quarterly CFF has increased by +$92.97 million (+624.73%).
- EVH quarterly CFF is now -71.60% below its all-time high of $379.73 million, reached on March 31, 2023.
Performance
EVH quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$92.41M+$92.97M(+16455.22%)Summary
- As of today (June 2, 2025), EVH TTM cash flow from financing activities is $92.41 million, with the most recent change of +$92.97 million (+16455.22%) on March 31, 2025.
- Over the past year, EVH TTM CFF has increased by +$175.91 million (+210.66%).
- EVH TTM CFF is now -83.65% below its all-time high of $565.29 million, reached on June 30, 2023.
Performance
EVH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EVH Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.2% | +624.7% | +210.7% |
| 3 y3 years | +98.1% | +309.9% | +464.7% |
| 5 y5 years | +98.4% | +231.1% | -13.4% |
EVH Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.2% | +98.1% | -71.6% | +204.3% | -83.7% | +144.0% |
| 5 y | 5-year | -100.2% | +98.4% | -71.6% | +204.3% | -83.7% | +144.0% |
| alltime | all time | -100.2% | +98.4% | -71.6% | +198.3% | -83.7% | +144.0% |
EVH Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $107.85M(+11.3%) | $92.41M(<-9900.0%) |
| Dec 2024 | -$565.00K(-100.2%) | $96.94M(-1176.2%) | -$565.00K(-99.7%) |
| Sep 2024 | - | -$9.01M(-91.3%) | -$181.86M(-13.5%) |
| Jun 2024 | - | -$103.38M(-794.7%) | -$210.22M(+151.7%) |
| Mar 2024 | - | $14.88M(-117.6%) | -$83.51M(-129.7%) |
| Dec 2023 | $281.34M(+113.9%) | -$84.35M(+125.7%) | $281.34M(-20.7%) |
| Sep 2023 | - | -$37.37M(-260.2%) | $354.84M(-37.2%) |
| Jun 2023 | - | $23.33M(-93.9%) | $565.29M(+0.5%) |
| Mar 2023 | - | $379.73M(-3598.5%) | $562.65M(+327.7%) |
| Dec 2022 | $131.54M(-545.2%) | -$10.85M(-106.3%) | $131.54M(-35.3%) |
| Sep 2022 | - | $173.08M(+736.5%) | $203.29M(+558.9%) |
| Jun 2022 | - | $20.69M(-140.3%) | $30.85M(-221.8%) |
| Mar 2022 | - | -$51.38M(-184.4%) | -$25.34M(-14.2%) |
| Dec 2021 | -$29.55M(+149.1%) | $60.90M(+9400.5%) | -$29.55M(-74.2%) |
| Sep 2021 | - | $641.00K(-101.8%) | -$114.36M(-11.3%) |
| Jun 2021 | - | -$35.50M(-36.1%) | -$128.86M(+28.8%) |
| Mar 2021 | - | -$55.58M(+132.4%) | -$100.02M(+743.2%) |
| Dec 2020 | -$11.86M(-66.6%) | -$23.92M(+72.6%) | -$11.86M(-1568.1%) |
| Sep 2020 | - | -$13.86M(+107.9%) | $808.00K(-99.3%) |
| Jun 2020 | - | -$6.66M(-120.5%) | $111.44M(+4.4%) |
| Mar 2020 | - | $32.57M(-389.6%) | $106.69M(-400.2%) |
| Dec 2019 | -$35.55M | -$11.25M(-111.6%) | -$35.55M(-113.8%) |
| Sep 2019 | - | $96.77M(-948.4%) | $257.66M(+64.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$11.41M(-89.6%) | $156.62M(-15.8%) |
| Mar 2019 | - | -$109.67M(-138.9%) | $185.97M(-32.1%) |
| Dec 2018 | $274.02M(+65.5%) | $281.96M(-6703.3%) | $274.02M(+1900.2%) |
| Sep 2018 | - | -$4.27M(-123.8%) | $13.70M(-92.5%) |
| Jun 2018 | - | $17.94M(-183.0%) | $181.50M(+19.0%) |
| Mar 2018 | - | -$21.61M(-199.9%) | $152.58M(-7.8%) |
| Dec 2017 | $165.56M(+10.2%) | $21.64M(-86.8%) | $165.56M(-43.5%) |
| Sep 2017 | - | $163.53M(-1588.6%) | $293.23M(+124.2%) |
| Jun 2017 | - | -$10.99M(+27.4%) | $130.78M(-7.6%) |
| Mar 2017 | - | -$8.63M(-105.8%) | $141.53M(-5.8%) |
| Dec 2016 | $150.19M(-29.9%) | $149.31M(>+9900.0%) | $150.19M(+2461.6%) |
| Sep 2016 | - | $1.08M(-572.9%) | $5.86M(+21.3%) |
| Jun 2016 | - | -$229.00K(-1016.0%) | $4.83M(-97.7%) |
| Mar 2016 | - | $25.00K(-99.5%) | $214.19M(+0.0%) |
| Dec 2015 | $214.16M(>+9900.0%) | $4.98M(+9129.6%) | $214.16M(+2.4%) |
| Sep 2015 | - | $54.00K(-100.0%) | $209.18M(+0.0%) |
| Jun 2015 | - | $209.13M(>+9900.0%) | $209.13M(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | -$961.00K(<-9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2014 | - | -$961.00K(-200.0%) | $0.00(-100.0%) |
| Mar 2014 | - | $961.00K | $961.00K |
| Dec 2013 | $34.29M | - | - |
FAQ
- What is Evolent Health annual cash flow from financing activities?
- What is the all time high annual CFF for Evolent Health?
- What is Evolent Health annual CFF year-on-year change?
- What is Evolent Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Evolent Health?
- What is Evolent Health quarterly CFF year-on-year change?
- What is Evolent Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Evolent Health?
- What is Evolent Health TTM CFF year-on-year change?
What is Evolent Health annual cash flow from financing activities?
The current annual CFF of EVH is -$565.00K
What is the all time high annual CFF for Evolent Health?
Evolent Health all-time high annual cash flow from financing activities is $281.34M
What is Evolent Health annual CFF year-on-year change?
Over the past year, EVH annual cash flow from financing activities has changed by -$281.90M (-100.20%)
What is Evolent Health quarterly cash flow from financing activities?
The current quarterly CFF of EVH is $107.85M
What is the all time high quarterly CFF for Evolent Health?
Evolent Health all-time high quarterly cash flow from financing activities is $379.73M
What is Evolent Health quarterly CFF year-on-year change?
Over the past year, EVH quarterly cash flow from financing activities has changed by +$92.97M (+624.73%)
What is Evolent Health TTM cash flow from financing activities?
The current TTM CFF of EVH is $92.41M
What is the all time high TTM CFF for Evolent Health?
Evolent Health all-time high TTM cash flow from financing activities is $565.29M
What is Evolent Health TTM CFF year-on-year change?
Over the past year, EVH TTM cash flow from financing activities has changed by +$175.91M (+210.66%)